Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  International Journal of Molecular Epidemiology and Genetics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 21686124PMCID PMC3110384
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Variations in Chromosomes 9 and 6p21.3 with Risk of Non–Hodgkin Lymphoma

  2010cited by this paper
• Prognostic biomarkers in malignant lymphomas

  2010cited by this paper
• Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium.

  2010influential reference
• Gene expression profiling in lymphoma diagnosis and management.

  2009cited by this paper
• Atopic disease and risk of non-Hodgkin lymphoma: an InterLymph pooled analysis.

  2009cited by this paper
• Genetic Variation in Tumor Necrosis Factor and the Nuclear Factor-κB Canonical Pathway and Risk of Non-Hodgkin's Lymphoma

  2008cited by this paper
• Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.

  2008cited by this paper
• Census and geographic differences between respondents and nonrespondents in a case-control study of non-Hodgkin lymphoma.

  2007cited by this paper
• Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).

  2007influential reference
• Molecular Epidemiology and Biomarkers in Etiologic Cancer Research: The New in Light of the Old

  2007cited by this paper
• Selection of controls in case-control studies on maternal medication use and risk of birth defects.

  2007influential reference
• Non‐Hodgkin lymphoma and obesity: A pooled analysis from the InterLymph Consortium

  2007cited by this paper
• Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.

  2007cited by this paper
• Obesity and risk of non-Hodgkin lymphoma (United States)

  2007cited by this paper
• Organochlorines and risk of non‐Hodgkin lymphoma

  2007cited by this paper
• Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph).

  2006cited by this paper
• Participation in population studies.

  2006cited by this paper
• Reporting participation in epidemiologic studies: a survey of practice.

  2006influential reference
• Family history of hematopoietic malignancy and risk of lymphoma.

  2005cited by this paper
• Molecular Epidemiology of Cancer

  2005cited by this paper
• Cigarette Smoking and Risk of Non-Hodgkin Lymphoma: A Pooled Analysis from the International Lymphoma Epidemiology Consortium (InterLymph)

  2005cited by this paper
• Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis.

  2005cited by this paper
• Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.

  2004influential reference
• Tobacco and Alcohol Consumption and the Risk of Non-Hodgkin Lymphoma

  2004cited by this paper
• Pigmentary characteristics, sun sensitivity and non‐Hodgkin lymphoma

  2004cited by this paper
• Modern Epidemiology Second Edition

  2003influential reference
• Alcohol use and risk of non-Hodgkin's lymphoma among Connecticut women (United States)

  2003cited by this paper
• Blood transfusions and risk of non-Hodgkin's lymphoma subtypes and chronic lymphocytic leukemia.

  2001cited by this paper
• Metabolic gene polymorphism frequencies in control populations.

  2001cited by this paper
• Molecular epidemiology, biomarkers and cancer prevention.

  2001cited by this paper
• Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California.

  1999cited by this paper
• Validation of a telephone questionnaire for Parkinson's disease.

  1998cited by this paper
• Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin's lymphoma.

  1997cited by this paper
• Logistics and design issues in the use of biological samples in observational epidemiology.

  1997cited by this paper
• Hospital or population controls? It depends on the question.

  1994cited by this paper
• Selection of controls in case-control studies. II. Types of controls.

  1992influential reference
• Selection of controls in case-control studies. I. Principles.

  1992cited by this paper
• Referral bias in multiple sclerosis research.

  1988cited by this paper
• The case-control study: valid selection of subjects.

  1985influential reference
• The "case-control" study: valid selection of subjects.

  1985cited by this paper
• Excluding controls: misapplications in case-control studies.

  1984cited by this paper
• Manual for scoring socioeconomic status for research on health behavior.

  1970influential reference

• Genetically determined body mass index is associated with diffuse large B‐cell lymphoma in polygenic and Mendelian randomization analyses

  2025cites this paper
• Evaluation of Etiologic Heterogeneity for Risk of Diffuse Large B-Cell Lymphoma Subtype Defined by Cell-of-Origin.

  2025cites this paper
• An Update of Evidence that the Herbicide Glyphosate (Roundup) is a Cause of Non-Hodgkin Lymphoma.

  2025cites this paper
• Medical history and lifestyle factors have limited impact on time‐to‐first‐treatment in patients with chronic lymphocytic leukemia

  2024cites this paper
• Blood Plasma Methylated DNA Markers in the Detection of Lymphoma: Discovery, Validation, and Clinical Pilot

  2024cites this paper
• Epidemiologic studies of glyphosate and non-Hodgkin's lymphoma: A review with consideration of exposure frequency, systemic dose, and study quality

  2023cites this paper
• B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS

  2022cites this paper
• Herbicide use in farming and other jobs in relation to non-Hodgkin’s lymphoma (NHL) risk

  2022cites this paper
• Physical activity and the risk of non‐Hodgkin lymphoma subtypes: A pooled analysis

  2022cites this paper
• Vaccination History and Risk of Lymphoma and Its Major Subtypes

  2021cites this paper
• Aspirin and other nonsteroidal anti‐inflammatory drugs, statins and risk of non‐Hodgkin lymphoma

  2021cites this paper
• Occupational insecticide exposure and risk of non‐Hodgkin lymphoma: A pooled case‐control study from the InterLymph Consortium

  2021cites this paper
• Association between periodontitis and Alzheimer’s disease and its impact on the self-perceived oral health status: a case-control study

  2020cites this paper
• Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL): an InterLymph Consortium study

  2020cites this paper
• Genome-wide Association Study Identifies HLA-DPB1 as a Significant Risk Factor for Severe Aplastic Anemia.

  2020cites this paper
• The association of health behaviors with quality of life in lymphoma survivors

  2020cites this paper
• The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population

  2019cites this paper
• Human Pegivirus infection and lymphoma risk and prognosis: a North American study

  2018cites this paper
• The association of physical activity before and after lymphoma diagnosis with survival outcomes

  2018cites this paper
• Allergic conditions are not associated with the risk of non-Hodgkin’s lymphoma or Hodgkin’s lymphoma: a systematic review and meta-analysis

  2017cites this paper
• Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia

  2017cites this paper
• Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study.

  2017cites this paper
• Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma.

  2016cites this paper
• Non-Hodgkin Lymphoma, Body Mass Index, and Cytokine Polymorphisms: A Pooled Analysis from the InterLymph Consortium

  2015cites this paper
• Risk of Non-hematologic Cancer in Individuals with High Count Monoclonal B-Cell Lymphocytosis (MBL)

  2015cites this paper
• Comprehensive serum cytokine analysis identi fi es IL-1RA and soluble IL-2R α as predictors of event-free survival in T-cell lymphoma

  2015cites this paper
• Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL loci.

  2015cites this paper
• Elevated serum levels of IL-2R, IL-1RA, and CXCL9 are associated with a poor prognosis in follicular lymphoma.

  2015cites this paper
• Elevated serum monoclonal and polyclonal free light chains and interferon inducible protein‐10 predicts inferior prognosis in untreated diffuse large B‐cell lymphoma

  2014cites this paper
• Medical history, lifestyle, family history, and occupational risk factors for lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

  2014cites this paper
• Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.

  2014influential citation
• Elevated soluble IL‐2Rα, IL‐8, and MIP‐1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma

  2014cites this paper
• Trans fatty acid intake is associated with increased risk and n3 fatty acid intake with reduced risk of non-hodgkin lymphoma.

  2013cites this paper
• Single-nucleotide polymorphism rs1052501 associated with monoclonal gammopathy of undetermined significance and multiple myeloma

  2013cites this paper
• CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis

  2013cites this paper
• Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls

  2013cites this paper
• Mapping of the IRF8 Gene Identifies a 3′UTR Variant Associated with Risk of Chronic Lymphocytic Leukemia but not Other Common Non-Hodgkin Lymphoma Subtypes

  2013cites this paper
• A Meta-Analysis of Hodgkin Lymphoma Reveals 19p13.3 TCF3 as a Novel Susceptibility Locus

  2013cites this paper
• Occupational exposure to immunologically active agents and risk for lymphoma: the European Epilymph case-control study.

  2013cites this paper
• A Two-Stage Evaluation of Genetic Variation in Immune and In fl ammation Genes with Risk of Non-Hodgkin Lymphoma Identi fi es New Susceptibility Locus in 6p21.3 Region Epidemiology,Biomarkers&Prevention

  2012cites this paper
• Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma

  2012cites this paper
• A Two-Stage Evaluation of Genetic Variation in Immune and Inflammation Genes with Risk of Non-Hodgkin Lymphoma Identifies New Susceptibility Locus in 6p21.3 Region

  2012cites this paper
• Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: a clinic-based case-control study.

  2012influential citation
• The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender.

  2012cites this paper
• Elevated pretreatment serum levels of interferon‐inducible protein‐10 (CXCL10) predict disease relapse and prognosis in diffuse large B‐cell lymphoma patients

  2012cites this paper
• Food‐frequency questionnaire‐based estimates of total antioxidant capacity and risk of non‐Hodgkin lymphoma

  2012cites this paper
• Oncotargets and Therapy Dovepress Dovepress

  year unknowncites this paper